Concepedia

Author

Valentina Vavassori

Istituto di Ricovero e Cura a Carattere Scientifico San RaffaeleORCID

Also Known As

Valentina Vavassori

20

Publications

934

Citations

10

H-Index

20

Concepts

All Affiliations

Istituto di Ricovero e Cura a Carattere Scientifico San RaffaeleVita-Salute San Raffaele UniversityIstituti di Ricovero e Cura a Carattere ScientificoThe San Raffaele Telethon Institute for Gene TherapyNational Research Council
VV

About

Valentina Vavassori is an author at Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele specializing in medicine, cell biology, and stem cell research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

315

2

Cell Biology

3

3

315

3

Health Sciences

1

1

54

4

Natural Sciences

1

1

66

5

Biomedical Engineering

1

1

66

Valentina Vavassori

×

9

Publications

867

Citations

9

H-Index

YearCitations

Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage Response

Giulia Schiroli, Anastasia Conti, Samuele Ferrari,

Cell stem cell

2019

327

Efficient gene editing of human long-term hematopoietic stem cells validated by clonal tracking

Samuele Ferrari, Aurélien Jacob, Stefano Beretta,

Nature Biotechnology

2020

195

Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cells

Samuele Ferrari, Aurélien Jacob, Daniela Cesana,

Cell stem cell

2022

120

Lipid nanoparticles allow efficient and harmless ex vivo gene editing of human hematopoietic cells

Valentina Vavassori, Samuele Ferrari, Stefano Beretta,

Blood

2023

66

Mobilization-based chemotherapy-free engraftment of gene-edited human hematopoietic stem cells

Attya Omer, Gabriele Pedrazzani, Luisa Albano,

Cell

2022

54

Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing for treating hyper‐IgM syndrome

Valentina Vavassori, E. Mercuri, Genni Enza Marcovecchio,

EMBO Molecular Medicine

2021

49

Exonic knockout and knockin gene editing in hematopoietic stem and progenitor cells rescues RAG1 immunodeficiency

Maria Carmina Castiello, Chiara Brandas, Samuele Ferrari,

Science Translational Medicine

2024

20

TIM-3, LAG-3, or 2B4 gene disruptions increase the anti-tumor response of engineered T cells

Beatrice Claudia Cianciotti, Zulma Magnani, Alessia Ugolini,

Frontiers in Immunology

2024

20

Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCs

Stefania Crippa, Anastasia Conti, Valentina Vavassori,

Molecular Therapy

2022

16

Page 1